×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder
Worldwide schedules comment Share
7871 views

Animateurs:

  • Dr Gwenaël Ferron, chirurgien oncologue Institut Universitaire du Cancer Toulouse
  • Coralie Marjollet, Imagyn

La Société Française de Chirurgie Oncologique s’associe à l’association IMAGYN pour un webinar ONCOSTREAM sur les Tumeurs Rares de l'Ovaire à destination des patientes et des professionnels de santé.

Quelques exemples des thèmes qui seront abordés lors de cette réunion interactive entre oncologues experts du groupe GINECO, spécialistes de soins de support et les patientes :

  • Qu'est-ce qu'une tumeur rare de l'ovaire ?
  • Pourquoi cela touche des femmes jeunes voire des adolescentes ?
  • Quels sont les traitements proposés et pourquoi ?
  • Comment prévenir et prendre en charge les séquelles de traitements, en particulier la fertilité, la ménopause, la sexualité ?
  • Comment accompagner au mieux les patientes et leurs familles? Place de l'association de patientes IMAGYN
  • Quel est le rôle du réseau de centres experts TMRO ?

Afin de pouvoir poser vos questions en direct aux intervenants un chat sera mis à votre disposition.

Shooting date : 2021-05-10
Last update : 2024-02-13
1 comment
Join the Discussion
  • Lauriane G. merci pour la presentation

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Monday, October 4th 2021 from 06pm to 07:30pm (GMT+2)
    Honolulu : Monday, October 4th 2021 from 07am to 08:30am (GMT+2)
    San Francisco : Monday, October 4th 2021 from 10am to 11:30am (GMT+2)
    New York : Monday, October 4th 2021 from 01pm to 02:30pm (GMT+2)
    Buenos Aires : Monday, October 4th 2021 from 02pm to 03:30pm (GMT+2)
    Reykjavik : Monday, October 4th 2021 from 05pm to 06:30pm (GMT+2)
    London / Dublin : Monday, October 4th 2021 from 06pm to 07:30pm (GMT+2)
    Paris / Berlin : Monday, October 4th 2021 from 07pm to 08:30pm (GMT+2)
    Istanbul : Monday, October 4th 2021 from 08pm to 09:30pm (GMT+2)
    Moscou / Dubaï : Monday, October 4th 2021 from 09pm to 10:30pm (GMT+2)
    Bangkok : Tuesday, October 5th 2021 from 12am to 01:30am (GMT+2)
    Shanghai : Tuesday, October 5th 2021 from 01am to 02:30am (GMT+2)
    Tokyo : Tuesday, October 5th 2021 from 02am to 03:30am (GMT+2)
    Sydney : Tuesday, October 5th 2021 from 04am to 05:30am (GMT+2)
    Wellington : Tuesday, October 5th 2021 from 06am to 07:30am (GMT+2)

    Cancer de l'ovaire : observance long terme sous inhibiteurs de PARP

    Episode 1

    Share
    Tuesday, April 12th 2022 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, April 12th 2022 from 07am to 08:30am (GMT+2)
    San Francisco : Tuesday, April 12th 2022 from 10am to 11:30am (GMT+2)
    New York : Tuesday, April 12th 2022 from 01pm to 02:30pm (GMT+2)
    Buenos Aires : Tuesday, April 12th 2022 from 02pm to 03:30pm (GMT+2)
    Reykjavik : Tuesday, April 12th 2022 from 05pm to 06:30pm (GMT+2)
    London / Dublin : Tuesday, April 12th 2022 from 06pm to 07:30pm (GMT+2)
    Paris / Berlin : Tuesday, April 12th 2022 from 07pm to 08:30pm (GMT+2)
    Istanbul : Tuesday, April 12th 2022 from 08pm to 09:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, April 12th 2022 from 09pm to 10:30pm (GMT+2)
    Bangkok : Wednesday, April 13th 2022 from 12am to 01:30am (GMT+2)
    Shanghai : Wednesday, April 13th 2022 from 01am to 02:30am (GMT+2)
    Tokyo : Wednesday, April 13th 2022 from 02am to 03:30am (GMT+2)
    Sydney : Wednesday, April 13th 2022 from 04am to 05:30am (GMT+2)
    Wellington : Wednesday, April 13th 2022 from 06am to 07:30am (GMT+2)

    Cancers séreux de bas grade

    Share
    Tuesday, November 15th 2022 from 06pm to 07:30pm (GMT+1)
    Honolulu : Tuesday, November 15th 2022 from 07am to 08:30am (GMT+1)
    San Francisco : Tuesday, November 15th 2022 from 09am to 10:30am (GMT+1)
    New York : Tuesday, November 15th 2022 from 12pm to 01:30pm (GMT+1)
    Buenos Aires : Tuesday, November 15th 2022 from 02pm to 03:30pm (GMT+1)
    London / Dublin : Tuesday, November 15th 2022 from 05pm to 06:30pm (GMT+1)
    Paris / Berlin : Tuesday, November 15th 2022 from 06pm to 07:30pm (GMT+1)
    Istanbul : Tuesday, November 15th 2022 from 07pm to 08:30pm (GMT+1)
    Moscou / Dubaï : Tuesday, November 15th 2022 from 09pm to 10:30pm (GMT+1)
    Bangkok : Wednesday, November 16th 2022 from 12am to 01:30am (GMT+1)
    Shanghai : Wednesday, November 16th 2022 from 01am to 02:30am (GMT+1)
    Tokyo : Wednesday, November 16th 2022 from 02am to 03:30am (GMT+1)
    Sydney : Wednesday, November 16th 2022 from 03am to 04:30am (GMT+1)
    Wellington : Wednesday, November 16th 2022 from 05am to 06:30am (GMT+1)

    Spécificités des soins de support dans le cancer de l'ovaire

    Share
    Thursday, March 14th 2024 from 06pm to 07:30pm (GMT+1)
    Honolulu : Thursday, March 14th 2024 from 07am to 08:30am (GMT+1)
    San Francisco : Thursday, March 14th 2024 from 09am to 10:30am (GMT+1)
    New York : Thursday, March 14th 2024 from 12pm to 01:30pm (GMT+1)
    Buenos Aires : Thursday, March 14th 2024 from 02pm to 03:30pm (GMT+1)
    London / Dublin : Thursday, March 14th 2024 from 05pm to 06:30pm (GMT+1)
    Paris / Berlin : Thursday, March 14th 2024 from 06pm to 07:30pm (GMT+1)
    Istanbul : Thursday, March 14th 2024 from 07pm to 08:30pm (GMT+1)
    Moscou / Dubaï : Thursday, March 14th 2024 from 09pm to 10:30pm (GMT+1)
    Bangkok : Friday, March 15th 2024 from 12am to 01:30am (GMT+1)
    Shanghai : Friday, March 15th 2024 from 01am to 02:30am (GMT+1)
    Tokyo : Friday, March 15th 2024 from 02am to 03:30am (GMT+1)
    Sydney : Friday, March 15th 2024 from 03am to 04:30am (GMT+1)
    Wellington : Friday, March 15th 2024 from 05am to 06:30am (GMT+1)

    Prise en charge du cancer de l’ovaire en L1 en région Nord/Normandie : où en sommes-nous ?

    Cycle d'enseignement sur le cancer de l'ovaire - Troisième session

    Share
    Scroll Up